Market Snapshot:
BAby formula lipid powder is widely used for the infant's growth, development, and to offer a proper nutrient diet to the infant. Baby formulas that contain OPO fat and alpha lipids have been becoming much popular to speed up brain connections and as replacer of human milk fat. Growing Awareness about the benefits of infant formulas among the parents and increasing demand for baby formulas that supports the immune system will create significant opportunities. The lipids used in the baby formulas are mainly derived from the dairy sources like milk or natural sources like coconut, and other plants.
Highlights from Baby Formula Lipid Powder Market Study
Attributes | Details |
---|
Study Period | 2018-2028 |
Base Year | 2022 |
Unit | Value (USD Million) |
The key Vendors profiled in the report are Nestle (Switzerland), DSM (Netherlands), Abbott Nutrition (United States), Bimbosan (Switzerland), Bellamy's Organic (Australia), Bonlife (Malaysia), AAK (Sweden), Topfer (Germany), Wakodo (Japan) and Kerry Group (Ireland).
Geographic Breakdown and Segment Analysis
The Global Baby Formula Lipid Powder market presents a comprehensive analysis of the Baby Formula Lipid Powder market by product type (Dairy Fat, Vegetable Oils and Other Oils & Fats), and by geography (North America, South America, Europe, Asia-Pacific and MEA) along with country level break-up. This section of our report presents a realistic picture of the Global Baby Formula Lipid Powder industry. Investors and Vendors can easily understand the inherent opportunities and challenges for their products in geographical region of interest.
For instance, while the holds majority of market share of the Baby Formula Lipid Powder market
Analyst at AMA have segmented the market study of Global Baby Formula Lipid Powder market by Type, Application and Region.
Influencing Trend:
Increased Focus on the Product Developments and Launches of New Types of Baby Formulas
Market Growth Drivers:
Growing Consumer Preference Towards Mimicking the Nutrition of Breast Milk and Surging Demand of Baby Formulas for Infant Nutrition and Growth
Challenges:
Lack of Maternal Infection-Fighting Antibodies in the Mimicking Formulas
Restraints:
High Cost Associated with Baby Formulas May Affect the Growth
Opportunities:
Increasing Working Mother Population Worldwide Especially in Developed Countries
Market Developments Activities:
In April 2020, Royal DSM, a global science-based nutrition, health, and sustainable living company, acquired Danish-headquartered Glycom A/S, the world's leading supplier of human milk oligosaccharides. By acquiring glycome, DMS adds HMO to its portfolio of nutritional lipids, vitamins, and nutrient premixes for the infant and toddler nutrition industry.
In 2020, DSM announced the launch of two new high-quality DHA and RHA lipid powders for infant nutrition. DHA and RHA play an important role in brain and cognitive development as well as the healthy immune system, bone formation, blood flow, etc. The new DHA and RHA lipid powders have been developed in order to support optimal growth and development during early life meet the expert recommendation for adding both DHA and ARA to infant formulas.
The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new product launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies.
Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Baby Formula Lipid Powder Manufacturers, Suppliers and Distributors of Baby Formula Lipid Powder, Venture Capitalists and Private Equity Firms, Government Regulatory and Research Organizations, End- Users and Others